1. Home
  2. EARN vs ACOG Comparison

EARN vs ACOG Comparison

Compare EARN & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.32

Market Cap

169.8M

Sector

Real Estate

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$8.90

Market Cap

193.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
ACOG
Founded
2012
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
169.8M
193.6M
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
EARN
ACOG
Price
$4.32
$8.90
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$5.38
$16.00
AVG Volume (30 Days)
356.2K
162.7K
Earning Date
06-16-2026
05-14-2026
Dividend Yield
20.51%
N/A
EPS Growth
N/A
41.58
EPS
N/A
N/A
Revenue
N/A
$10,220,275.00
Revenue This Year
$7.69
$139.22
Revenue Next Year
$19.57
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$4.50
52 Week High
$5.77
$10.14

Technical Indicators

Market Signals
Indicator
EARN
ACOG
Relative Strength Index (RSI) 41.40 47.57
Support Level $4.29 $5.28
Resistance Level $4.49 $9.04
Average True Range (ATR) 0.07 0.55
MACD -0.01 -0.09
Stochastic Oscillator 2.38 3.91

Price Performance

Historical Comparison
EARN
ACOG

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co The Fund is focused on acquiring and actively managing a portfolio of corporate CLOs, mainly mezzanine debt and equity tranches, which are typically collateralized by portfolios consisting mainly of below-investment-grade senior secured loans with a large number of discrete underlying borrowers across various industry sectors. Additionally, the Fund may also invest in CLO loan accumulation facilities, which are entities that acquire corporate loans and other similar corporate credit-related assets in anticipation of ultimately collateralizing a CLO transaction. The company's primary investment objectives are to generate attractive current income and risk-adjusted total returns for shareholders.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: